Cogstate Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 4/6

Cogstate verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 50%, während die Gewinne der Branche Healthcare Services jährlich um gewachsen und zwar um 13.1%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 15.9%. Die Eigenkapitalrendite von Cogstate beträgt 14.5% und die Nettomargen betragen 13.4%.

Wichtige Informationen

50.0%

Wachstumsrate der Gewinne

51.7%

EPS-Wachstumsrate

Healthcare Services Wachstum der Industrie	42.6%
Wachstumsrate der Einnahmen	15.9%
Eigenkapitalrendite	14.5%
Netto-Marge	13.4%
Nächste Ertragsaktualisierung	22 Aug 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Mar 23

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

Mar 02

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Jan 13

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Oct 04

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Sep 28

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Sep 02

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Jun 30

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

Mar 22

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Oct 20

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Jul 23

Is Cogstate (ASX:CGS) Using Too Much Debt?

Apr 29

What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Mar 14

Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like

Feb 21

How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?

Jan 17

Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?

Dec 05

Aufschlüsselung der Einnahmen und Ausgaben

Wie Cogstate Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

ASX:CGS Einnahmen, Ausgaben und Erträge (USD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
31 Dec 23	41	6	16
30 Sep 23	41	5	16
30 Jun 23	40	4	16
31 Mar 23	41	4	15
31 Dec 22	41	3	14
30 Sep 22	43	6	14
30 Jun 22	45	8	13
31 Mar 22	43	9	13
31 Dec 21	42	10	13
30 Sep 21	37	7	12
30 Jun 21	33	5	12
31 Mar 21	30	3	11
31 Dec 20	28	0	10
30 Sep 20	25	-1	10
30 Jun 20	23	-2	10
31 Mar 20	21	-3	10
31 Dec 19	19	-3	10
30 Sep 19	21	-3	11
30 Jun 19	22	-2	12
31 Mar 19	24	-2	14
31 Dec 18	27	-1	15
30 Sep 18	28	-1	15
30 Jun 18	29	-1	15
31 Mar 18	27	-2	15
31 Dec 17	26	-3	14
30 Sep 17	26	-2	14
30 Jun 17	26	-1	14
31 Mar 17	26	0	13
31 Dec 16	24	1	13
30 Sep 16	23	1	12
30 Jun 16	20	2	11
31 Mar 16	19	1	10
31 Dec 15	17	0	9
30 Sep 15	14	-2	9
30 Jun 15	12	-4	9
31 Mar 15	11	-3	8
31 Dec 14	10	-3	8
30 Sep 14	10	-3	9
30 Jun 14	11	-4	9
31 Mar 14	11	-4	9
31 Dec 13	11	-4	9
30 Sep 13	11	-3	9
30 Jun 13	11	-2	8

Qualität der Erträge: CGS einen hohen Anteil an unbarem Gewinn hat.

Wachsende Gewinnspanne: CGSDie aktuellen Gewinnspannen (13.4%) sind höher als im letzten Jahr (8.4%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: CGS ist in den letzten 5 Jahren profitabel geworden und hat seinen Gewinn um 50% pro Jahr gesteigert.

Beschleunigtes Wachstum: CGSDas Gewinnwachstum des Unternehmens im letzten Jahr (57.6%) übertrifft seinen 5-Jahres-Durchschnitt (50% pro Jahr).

Erträge im Vergleich zur Industrie: CGS Das Gewinnwachstum im vergangenen Jahr (57.6%) übertraf das der Branche Healthcare Services 8.6% .

Eigenkapitalrendite

Hohe Eigenkapitalrendite: CGSDie Eigenkapitalrendite des Unternehmens (14.5%) wird als niedrig angesehen.

Cogstate Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

First half 2024 earnings released: EPS: US$0.012 (vs US$0 in 1H 2023)

Cogstate Limited to Report First Half, 2024 Results on Feb 22, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

First half 2023 earnings released: EPS: US$0 (vs US$0.024 in 1H 2022)

Cogstate Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Full year 2022 earnings: EPS misses analyst expectations

Recent updates

If EPS Growth Is Important To You, Cogstate (ASX:CGS) Presents An Opportunity

First half 2024 earnings released: EPS: US$0.012 (vs US$0 in 1H 2023)

Price target decreased by 8.1% to AU$1.70

Investor sentiment deteriorates as stock falls 17%

The Price Is Right For Cogstate Limited (ASX:CGS)

Cogstate Limited to Report First Half, 2024 Results on Feb 22, 2024

Price target increased by 8.6% to AU$1.85

Cogstate Limited Provides Revenue Guidance for 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?

Now 21% undervalued

Price target decreased by 9.0% to AU$1.70

Now 23% undervalued

Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023

Consensus EPS estimates increase by 12%

Returns Are Gaining Momentum At Cogstate (ASX:CGS)

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Consensus revenue estimates increase by 11%

Investor sentiment deteriorates as stock falls 16%

CEO, MD & Executive Director recently bought AU$100k worth of stock

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

First half 2023 earnings released: EPS: US$0 (vs US$0.024 in 1H 2022)

Consensus EPS estimates increase by 23%, revenue downgraded

Investor sentiment deteriorates as stock falls 25%

Now 24% undervalued

Cogstate Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 22% undervalued

Cogstate Limited Announces Resignation of David Dolby as Non-Executive Director

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Price target decreased to AU$1.92

High number of new and inexperienced directors

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Price target decreased to AU$2.18

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to AU$2.41

Cogstate Limited Provides Earnings Guidance for the Fiscal Year 2023

High number of new and inexperienced directors

Price target decreased to AU$2.43

Investor sentiment improved over the past week

High number of new and inexperienced directors

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Cogstate Announces Formation of Scientific Advisory Board

Consensus EPS estimates fall by 82%

Investor sentiment improved over the past week

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Independent Non-Executive Director exercised options to buy AU$244k worth of stock.

Non-Executive Chairman recently sold AU$89k worth of stock

Non-Executive Chairman exercised options and sold AU$188k worth of stock

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS US$0.031 (vs US$0.008 loss in FY 2020)

Insider recently sold AU$1.8m worth of stock

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Insider recently sold AU$1.3m worth of stock

Is Cogstate (ASX:CGS) Using Too Much Debt?

CEO, MD & Executive Director exercised options to buy AU$679k worth of stock.

What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?

Cogstate Announces Company Secretary Changes

Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like

How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?

Cogstate Limited to Report Q4, 2021 Results on Jul 28, 2021

Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?

Cogstate Appoints Kim Wenn as Independent Non-Executive Director